Answers are grounded in this paper and cite their sources.
This document is intended as a supplement to the EANM "Guidelines on current Good Radiopharmacy Practice (cGRPP)" issued by the Radiopharmacy Committee of the EANM (Gillings et al. in EJNMMI Radiopharm Chem. 6:8, 2021). The aim of the EANM Radiopharmacy Committee is to provide a document that describes how to manage risks associated with small-scale "in-house" preparation of radiopharmaceuticals, not intended for commercial purposes or distribution.
No takes yet. Share an insight, caveat, or question.
Gillings et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: